PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 25206483-10 2013 These results suggest that 8-OH-DPAT inhibits Bax and caspase-3 expression, increases Bcl-2 expression, and reduces neural cell apoptosis, resulting in neuroprotection against diffuse axonal injury. 8-Hydroxy-2-(di-n-propylamino)tetralin 27-36 caspase 3 Rattus norvegicus 54-63 26819921-0 2015 Effect of Buspirone, Fluoxetine and 8-OH-DPAT on Striatal Expression of Bax, Caspase-3 and Bcl-2 Proteins in 6-Hydroxydopamine-Induced Hemi-Parkinsonian Rats. 8-Hydroxy-2-(di-n-propylamino)tetralin 36-45 caspase 3 Rattus norvegicus 77-86 26819921-3 2015 In this study we investigated the effect of sub-chronic administration of buspirone, fluoxetine and 8-hydroxy-2-[di-n-propylamino]tetralin (8-OH-DPAT) in 6-hydroxydopamine (6-OHDA)-lesioned rats and assayed striatal concentrations of apoptotic (Bax, Caspase3) and anti-apoptotic (Bcl-2) proteins. 8-Hydroxy-2-(di-n-propylamino)tetralin 140-149 caspase 3 Rattus norvegicus 250-258 26819921-6 2015 RESULTS: The results showed that the expression of Bax and caspase3 proteins was increased three weeks after 6-OHDA injection while they were decreased significantly in parkinsonian rats which were treated by buspirone, fluoxetine and 8-OH-DPAT. 8-Hydroxy-2-(di-n-propylamino)tetralin 235-244 caspase 3 Rattus norvegicus 59-67 15661577-5 2005 In addition, 8-OH-DPAT inhibited the H(2)O(2)-induced elevation of glutamate release into the medium and cytosolic Ca(2+) concentration ([Ca(2+)](c)), generation of reactive oxygen species (ROS), and caspase-3 activity. 8-Hydroxy-2-(di-n-propylamino)tetralin 13-22 caspase 3 Rattus norvegicus 200-209 12604665-4 2003 NMDA-induced caspase-3 activity and DNA fragmentation were almost completely blocked by the 5-HT1A agonists 8-hydroxy-2-(di-n-propylamino)-tetralin (8-OH-DPAT) and (R)-5-fluoro-8 hydroxy-2-(dipropylamino)-tetralin (R-UH-301). 8-Hydroxy-2-(di-n-propylamino)tetralin 108-147 caspase 3 Rattus norvegicus 13-22 12604665-4 2003 NMDA-induced caspase-3 activity and DNA fragmentation were almost completely blocked by the 5-HT1A agonists 8-hydroxy-2-(di-n-propylamino)-tetralin (8-OH-DPAT) and (R)-5-fluoro-8 hydroxy-2-(dipropylamino)-tetralin (R-UH-301). 8-Hydroxy-2-(di-n-propylamino)tetralin 149-158 caspase 3 Rattus norvegicus 13-22 12604665-5 2003 Additionally, the protective effects of 8-OH-DPAT and R-UH-301 on NMDA-induced caspase-3 activation and apoptosis were reversed by pretreatment with the 5-HT1A antagonists N-[2-[4-(2-methoxyphenyl)-1-piperazinyl] ethyl]-N-(2-pyridinyl) cyclohexane carboxamide (WAY 100635) and S-UH-301, respectively. 8-Hydroxy-2-(di-n-propylamino)tetralin 40-49 caspase 3 Rattus norvegicus 79-88 12604665-7 2003 Caspase-3 activation and DNA fragmentation in primary mesencephalic neurons were almost completely inhibited by 8-OH-DPAT. 8-Hydroxy-2-(di-n-propylamino)tetralin 112-121 caspase 3 Rattus norvegicus 0-9